↓ Skip to main content

Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil

Overview of attention for article published in Revista Brasileira de Psiquiatria, September 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
1 X user
peer_reviews
1 peer review site

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
102 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil
Published in
Revista Brasileira de Psiquiatria, September 2015
DOI 10.1590/1516-4446-2014-1516
Pubmed ID
Authors

Carlos R. Maia, Steffan F. Stella, Flavia Wagner, Thiago G. Pianca, Fernanda V. Krieger, Luciane N. Cruz, Guilherme V. Polanczyk, Luis A. Rohde, Carísi A. Polanczyk

Abstract

To perform a cost-utility analysis on the treatment of attention deficit hyperactivity disorder (ADHD) with methylphenidate immediate-release (MPH-IR) in children and adolescents from Brazil. A Markov model was constructed to compare MPH-IR vs. no treatment. A 24-week naturalistic study was conducted to collect transition probabilities and utility data. Effectiveness was expressed as quality-adjusted life-years (QALY), and costs reported in 2014 international dollars (I$). The perspective was the Brazilian Unified Health System as payer, and the time horizon was 6 years. Of 171 patients, 73 provided information at baseline, and 56 at week 24. Considering the MPH-IR monthly cost of I$ 38, the incremental cost-effectiveness ratio (ICER) of treatment was I$ 9,103/QALY for children and I$ 11,883/QALY for adolescents. In two-way sensitivity analysis, considering one Gross National Product per capita (I$ 11,530) as willingness-to-pay, a cost of no-treatment lower than I$ 45/month would render MPH-IR a cost-saving strategy. MPH-IR treatment of children and adolescents is cost-effective for ADHD patients from the Brazilian public health system perspective. Both patients and the healthcare system might benefit from such a strategy. NCT01705613.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 3 3%
Unknown 99 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 15%
Student > Master 12 12%
Student > Ph. D. Student 7 7%
Student > Bachelor 7 7%
Student > Doctoral Student 6 6%
Other 17 17%
Unknown 38 37%
Readers by discipline Count As %
Medicine and Dentistry 18 18%
Psychology 8 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 7%
Social Sciences 6 6%
Nursing and Health Professions 4 4%
Other 13 13%
Unknown 46 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2022.
All research outputs
#2,646,709
of 25,611,630 outputs
Outputs from Revista Brasileira de Psiquiatria
#85
of 904 outputs
Outputs of similar age
#34,046
of 280,343 outputs
Outputs of similar age from Revista Brasileira de Psiquiatria
#3
of 12 outputs
Altmetric has tracked 25,611,630 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 904 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,343 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.